Two Sigma Investments’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-76,990
| Closed | -$430K | – | 3381 |
|
2025
Q1 | $430K | Sell |
76,990
-62,693
| -45% | -$350K | ﹤0.01% | 2527 |
|
2024
Q4 | $1.13M | Sell |
139,683
-44,392
| -24% | -$358K | ﹤0.01% | 2042 |
|
2024
Q3 | $1.89M | Sell |
184,075
-78,439
| -30% | -$804K | ﹤0.01% | 1665 |
|
2024
Q2 | $1.86M | Buy |
262,514
+153,505
| +141% | +$1.09M | ﹤0.01% | 1534 |
|
2024
Q1 | $1.5M | Buy |
109,009
+3,999
| +4% | +$55K | ﹤0.01% | 1641 |
|
2023
Q4 | $966K | Buy |
105,010
+73,896
| +238% | +$680K | ﹤0.01% | 2028 |
|
2023
Q3 | $188K | Sell |
31,114
-75,501
| -71% | -$457K | ﹤0.01% | 2577 |
|
2023
Q2 | $827K | Buy |
106,615
+63,195
| +146% | +$490K | ﹤0.01% | 1986 |
|
2023
Q1 | $247K | Sell |
43,420
-3,149
| -7% | -$17.9K | ﹤0.01% | 2420 |
|
2022
Q4 | $274K | Sell |
46,569
-127,496
| -73% | -$751K | ﹤0.01% | 2216 |
|
2022
Q3 | $557K | Sell |
174,065
-61,271
| -26% | -$196K | ﹤0.01% | 1682 |
|
2022
Q2 | $1.05M | Sell |
235,336
-84,019
| -26% | -$376K | ﹤0.01% | 1468 |
|
2022
Q1 | $1.71M | Buy |
+319,355
| New | +$1.71M | 0.01% | 1399 |
|
2021
Q3 | – | Sell |
-30,641
| Closed | -$542K | – | 2853 |
|
2021
Q2 | $542K | Buy |
+30,641
| New | +$542K | ﹤0.01% | 1929 |
|